Sensei Bio

Sensei Biotherapeutics, headquartered in Rockville, Maryland, is a privately held company. The company specializes in biotechnology solutions with eight employees. Sensei Biotherapeutics focuses on immuno-oncology, developing therapeutic solutions to specifically target the tumor microenvironment and strengthen the body's natural defenses against cancer. Their proprietary TMAb™ platform allows for highly selective targeting of immune system interactions with tumor cells, essentially altering the perception of cancer so that the body's defenses can effectively attack it. Sensei's dedication centers on translating cutting-edge immunological, oncological, and biological knowledge into real-world therapeutic options. Guided by rigorous research and driven by empathy, their ultimate goal is to improve treatment outcomes for individuals facing cancer diagnosis and the medical professionals dedicated to their care. Companies can learn more by visiting senseibio.com.